Cardax Overview

  • Founded
  • 2006
Founded
  • Status
  • Public
  • Employees
  • 20
Employees
  • Stock Symbol
  • CDXI
Stock Symbol
  • Share Price
  • $0.45
  • (As of Friday Closing)

Cardax General Information

Description

Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health products in the United States. The firm's platform has applications in arthritis, metabolic syndrome, liver disease, and cardiovascular disease, as well as macular degeneration and prostate disease. It is focused on the development of astaxanthin technologies. The group's product ZanthoSyn is marketed as a novel astaxanthin dietary supplement. Astaxanthin is a clinically studied ingredient with a safe anti-inflammatory activity that supports joint health, cardiovascular health, metabolic health, and liver health. Geographically, it generates maximum revenue from the United States.

Contact Information

Formerly Known As
Koffee Korner
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
  • 2800 Woodlawn Drive
  • Suite 129
  • Honolulu, HI 96822
  • United States
+1 (808) 000-0000

Cardax Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardax Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.45 $0.81 $0.05 - $2.00 $361K 803K 3.5K -$7.07

Cardax Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 5,945 5,525 9,350 26,469
Revenue 501 539 711 1,511
EBITDA (3,026) (2,636) (4,430) (3,991)
Net Income (5,435) (5,056) (5,093) (4,024)
Total Assets 1,378 1,425 2,019 2,459
Total Debt 5,395 4,784 2,597 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cardax Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial

Cardax Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Cardax Inc is a life sciences company engaged in the development of marketing, and distribution of consumer health produ
Drug Discovery
Honolulu, HI
20 As of 2021
000.00
000000000 000.00

00000000

m ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
000000000000000
Ingelheim am Rhein, Germany
00000 As of 0000

000000

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Bridgewater, NJ
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardax Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Boehringer Ingelheim Corporation Ingelheim am Rhein, Germany 00000
000000 Corporation Bridgewater, NJ 000 00000 000000 - 000 00000
000000 000000 Corporate Backed or Acquired Laval, Canada 00 000.00 000000000 000.00
000000 00000000000 Accelerator/Incubator Backed Somerville, MA 0 00000 0000000000 00000
00000000 000000 Corporate Backed or Acquired Tokyo, Japan 00000 00000000000
You’re viewing 5 of 10 competitors. Get the full list »

Cardax Patents

Cardax Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200085776-A1 Methods of reducing c-reactive protein and/or treating cardiovascular disease Abandoned 10-Sep-2018 0000000000
US-8063101-B2 Carotenoid analogs and derivatives for the prevention of platelet aggregation Active 23-Mar-2007 000000000 0
US-20090124574-A1 Carotenoid analogs and derivatives for the prevention of platelet aggregation Granted 23-Mar-2007 000000000 0
US-20080221377-A1 Coupling chemical intermediate to form carotenes or xanthophylls, used as free radical scavengers; cytoprotective agents; oxidation resistance Abandoned 16-Jun-2006 000000000 0
US-20090099061-A1 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics Abandoned 27-Jan-2006 C07C39/21 0
To view Cardax’s complete patent history, request access »

Cardax Executive Team (6)

Name Title Board Seat Contact Info
David Watumull Co-Founder, Board Member, President & Chief Executive Officer
John Russell Chief Financial Officer
David Watumull Chief Operating Officer
Paresh Soni MD Chief Clinical and Regulatory Strategist & SAB Member
You’re viewing 4 of 6 executive team members. Get the full list »

Cardax Board Members (7)

Name Representing Role Since
David Watumull Cardax Co-Founder, Board Member, President & Chief Executive Officer 000 0000
Elona Kogan JD Self Board Member 000 0000
George Bickerstaff III Self Chairman 000 0000
Michele Galen JD Cardax Board Member 000 0000
Terence Kelly Ph.D Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cardax Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardax Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cardax‘s full profile, request access.

Request a free trial